The impact of Acinetobacter baumannii in the intensive care unit

Anaesthesia

Volumn 58, Issue 3, 2003, Pages 271-274

  Theaker, C ^a   Azadian, B ^a   Soni, N ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Acinetobacter baumannii; Intensive care: adult, mortality; Resistant organisms

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DEATH; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG SCREENING; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; MORTALITY; NONHUMAN; POPULATION; PROSPECTIVE STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTENSIVE CARE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES;

EID: 0037342942     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.30403.x     Document Type: Article

References (23)

1. Go ES, Urban C, Burns J et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactum. Lancet 1994; 344: 1329-32.
2. Urban C, Go E, Mariano N et al. Effect of sulbactum on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype. Antiratus Journal of Infectious Diseases 1993; 167: 448-51.
3. Roberts SA, Findlay R, Lang SD. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. Journal of Hospital Infection 2001; 48: 228-32.
4. Mah MW, Memish ZA, Cunningham G, Bannatyne RM. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy. American Journal of Infection Control 2001; 29: 284-8.
5. Kaul R, Burt JA, Cork L et al. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: Risk factors and attributable mortality. Journal of Infectious Diseases 1996; 174: 1279-87.
6. Crowe M, Towner KJ, Humphreys H. Clinical and epidemiological features of an outbreak of Acinetobacter infection in an intensive therapy unit. Journal of Medical Microbiology 1995; 43: 55-62.
7. Fierobe L, Lucet JC, Decre D et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Hospital Epidemiology and Infection Control 2001; 22: 35-40.
8. Beck-Sague CM, Jarvis WR, Brook JH et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. American Journal of Epidemiology 1990; 132: 723-33.
9. Patil JR, Chopade BA. Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. National Medical Journal of India 2001; 14: 204-8.
10. Das I, Lambert P, Hill D, Noy M, Bion J, Elliot T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. Journal of Hospital Infection 2002; 50: 110-14.
11. Pasdeloup T. Muco-cutaneous colonization and nosocomial infections caused by methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in intensive care patients. Pathologie et Biologie (Paris) 2000; 48: 533-40.
12. Chastre J, Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Seminars in Respiratory Infections 2000; 15: 287-98.
13. Lortholary O, Fagon JY, Hoi AB et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: Risk factors and prognosis. Clinical Infectious Diseases 1995; 20: 790-6.
14. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections. American Journal of Infection Control 1988; 16: 128-40.
15. Sader HS, Mendes CF, Pignatari AC et al. Use of macro-restriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in San Paulo, Brazil. Clinical Infectious Diseases 1996; 23: 631-4.
16. Tankovic J, Legrand P, DeGatines G et al. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. Journal of Clinical Microbiology 1994; 32: 2677-81.
17. Theaker C, Ormond-Walshe S, Azadian B, Soni N. MRSA in the critically ill. Journal of Hospital Infection 2001; 48: 98-102.
18. Iblings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: Acquisition and risk of death in patients in the intensive care unit. European Journal of Surgery 1998; 164: 411-18.
19. Cheong I, Samsudin LM, Law GH. Methicillin-resistant Staphylococcus aureus bacteraemia at a tertiary teaching hospital. British Journal of Clinical Practice 1996; 50: 237-9.
20. Ceollo R, Jiminez J, Garcia M et al. Prospective study of infection, colonisation and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 74-81.
21. Longfield JN, Townsend TR, Cruess DF et al. Methicillin-resistant Staphylococcus aureus (MRSA): Risk and outcome of colonised vs. infected patients. Infection Control 1985; 6: 445-50.
22. Romero Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 1995; 21: 1417-23.
23. Soriano A, Martinez JA, Mensa J et al. Pathogenic significance or methicillin resistance for patients with Staphylococcus aureus bacteraemia. Clinical Infectious Diseases 2000; 30: 368-73.